IndraLab

Statements


| 5 7

sparser
"Furthermore, administration of a CCL2 competitor reduced monocyte recruitment, which attenuated MI-R injury ( xref ), and pharmacological blockage of the CCL5-CXCR4 interaction impaired the inflammatory response resulting in a reduced infarct size and preserved cardiac function ( xref )."

sparser
"For example, inhibition of platelet derived CXCR4CCL5 heterodimer formation was shown to attenuate monocyte recruitment to inflamed vessel wall inApoE −/− mice xref and also reduce aneurysm formation in those animals."

sparser
"To examine the effects of MKEY in healing following I/R, 8 week-old male mice were treated with MKEY or sMKEY to block specific CCL5-CXCR4 interactions."

reach
"For example, inhibition of platelet derived CXCR4 and CCL5 heterodimer formation was shown to attenuate monocyte recruitment to inflamed vessel wall in ApoE -/- mice XREF_BIBR and also reduce aneurysm formation in those animals."

reach
"Additionally, obstructing the interaction between CC motif chemokine 5 (CCL5) and CXC motif chemokine receptor 4 (CXCR4) in MI shrank infarct size, conserved heart function, and was related to a reduced presence of neutrophils and the formation of neutrophil extracellular traps [34]."

sparser
"The downregulation of CXCR4 was specific for SDF-1α and was not observed when the cells were treated with RANTES, which does not bind CXCR4 (Fig. xref , a–c )."

sparser
"Another recent mouse study presented protective and anti-inflammatory effects of MKEY (a specific peptide blocking the CCL5-CXCR4 interaction) in a myocardial ischemia/reperfusion injury model and suggested that it could be used therapeutically in atherosclerosis and myocardial infarction treatment [ xref ]."

reach
"FGF21 synergistically blocks CXCR4 and CCL5 interaction on the hepatocytes to inhibit the production of TGFbeta, IL-6, IL-1, RANTES, Col1, and elastin."

reach
"CCL3 and MIP1alpha binding to CCR5 STA mutant receptor reduced its ability to form heterodimer with CXCR4, while the binding of CCL5 and RANTES to CCR5 or CXCL12 and SDF -1 to CXCR4 had no apparent effect."

sparser
"The β chemokine Rantes, which does not bind CXCR4, had no effect on infection."

sparser
"A specifically designed compound (MKEY) to block this CCL5-CXCR4 interaction is investigated as a potential therapeutic in a model of myocardial ischemia/reperfusion (I/R) damage."

reach
"The immune checkpoint module (Figure 7A) revealed interactions between CCL5, CCR1, CXCL12, and CXCR4."